국가: 뉴질랜드
언어: 영어
출처: Medsafe (Medicines Safety Authority)
Isosorbide mononitrate 40mg;
Novartis New Zealand Ltd
Isosorbide mononitrate 40 mg
40 mg
Modified release tablet
Active: Isosorbide mononitrate 40mg Excipient: Colloidal silicon dioxide Hydrated silica Hypromellose Lactose monohydrate Macrogol 4000 Magnesium stearate Polyvidone 30
Blister pack, 30 tablets
Prescription
Prescription
Cambrex Karlskoga AB
Corangin is indicated for: · Prevention of angina pectoris attacks, and also in cases where symptoms of angina pectoris persist after myocardial infarction. Corangin may be used either as monotherapy or in combination with other antianginal agents (e.g. beta-blockers or calcium antagonists).
Package - Contents - Shelf Life: Blister pack, - 30 tablets - 36 months from date of manufacture stored at or below 25°C
1989-07-20
__________________________________________________________________________________________________ Corangin ® 1 CORANGIN ® _40mg tablet _ _isosorbide-5-mononitrate_ _____________________________________________________________________________________ CONSUMER MEDICINE INFORMATION ____________________ WHAT IS IN THIS LEAFLET __________________________________ This leaflet answers some common questions about Corangin. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you having Corangin against the benefits they expect it will provide. IF YOU HAVE ANY CONCERNS ABOUT THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET. You may need to read it again. ________________________ WHAT CORANGIN IS USED FOR ________________________ Corangin contains the active ingredient isosorbide-5- mononitrate. It belongs to a class of medicines know as organic nitrate vasodilators, meaning that they cause blood vessels to widen. Widening the blood vessels means that blood flow and blood pressure is improved, and so the heart does not need to do as much work and does not need as much oxygen. Corangin is used to prevent angina pectoris and to treat heart failure. It is not suitable for the treatment of acute attacks of angina pectoris. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY THIS MEDICINE HAS BEEN PRESCRIBED FOR YOU. Your doctor may have prescribed it for another purpose. Corangin is only available with a doctor's prescription. It is not add 전체 문서 읽기
NEW ZEALAND DATA SHEET CORANGIN ® ISOSORBIDE-5-MONONITRATE TRADE NAME CORANGIN ® 40 mg and 60 mg slow release divisible tablets DESCRIPTION AND COMPOSITION PHARMACEUTICAL FORMS Slow-release tablets , divisible (Divitabs ® ), containing 40 or 60 mg isosorbide-5-mononitrate. ACTIVE SUBSTANCE Isosorbide-5-mononitrate. One tablet contains 40 mg or 60 mg. ACTIVE MOIETY Isosorbide-5-mononitrate. EXCIPIENTS Tablets (40 mg, 60 mg): silicagel, aerosil 200, lactose, magnesium stearate, Methocel K 100 M premium (hydroxypropyl-methylcellulose), polyethylenglycol 4000, polyvinylpyrrolidon K 30. INDICATIONS Corangin is indicated for: • Long term treatment of ischemic heart disease, • Prevention of angina pectoris attacks, and also in cases where symptoms of angina pectoris persist after myocardial infarction. Corangin may be used either as monotherapy or in combination with other antianginal agents (e.g. beta-blockers or calcium antagonists). • Treatment for chronic heart failure, in combination with digitalis or other positive-inotropic agents and/or diuretics. DOSAGE AND ADMINISTRATION GENERAL RULES Corangin is not intended for the immediate relief of acute attacks of angina pectoris; if they occur, the additional use of rapid-acting nitrate preparations is indicated. Development of tolerance or attenuation of effect may occur with all long-acting nitrates in individual patients on continuous treatment. This can be reversed with low-nitrate blood levels (as observed with Corangin at the end of the dosing interval). ANGINA PECTORIS The starting dose should be 1 tablet of Corangin 40 mg once daily and increased as required, either by adding one-half of a 40 mg tablet or changing to the 60 mg tablet. Depending on the time of day at which the angina pectoris attacks occur in the individual patient, the slow- release tablet can be taken either in the morning or in the evening. If treatment with Coran 전체 문서 읽기